Live Breaking News & Updates on Foreign Born State Specific Population

Stay updated with breaking news from Foreign born state specific population. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition

BOSTON (BUSINESS WIRE) Dec 11, 2023 ....

United States , Saudi Arabia , City Of , United Kingdom , Great Britain , Exagamglogene Autotemcel , Heather Nichols , Manisha Pai , Carmen Bozic , Exchange Commission , Global Medicines Development , Vertex Pharmaceuticals Incorporated Nasdaq , American Society Of Hematology , Vertex Pharmaceuticals Incorporated , Drug Agency , Occlusive Crisis On Health , Regulatory Agency , National Health Regulatory Authority , Companies To Work , European Medicines Agency , Drug Administration , Improvements In Health , Pharmaceuticals Incorporated , American Society , Annual Meeting , Executive Vice President ,

Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Pres

- Longer-term follow-up data demonstrate consistent and durable response to treatment -BOSTON (BUSINESS WIRE) Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced two oral presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition from the global pivotal trials of CASGEVY. ....

Saudi Arabia , United Kingdom , City Of , United States , Great Britain , Manisha Pai , Heather Nichols , Exagamglogene Autotemcel , Carmen Bozic , Occlusive Crisis On Health , National Health Regulatory Authority , Drug Administration , Regulatory Agency , Improvements In Health , Vertex Pharmaceuticals Incorporated , Drug Agency , Companies To Work , Exchange Commission , European Medicines Agency , Vertex Pharmaceuticals Incorporated Nasdaq , American Society Of Hematology , Global Medicines Development , American Society , Annual Meeting , Executive Vice President , Medical Affairs ,

Vertex to Present New Data on Exagamglogene Autotemcel (exa-cel) at the American Society of Hematology (ASH) Annual Meeting and Exposition

- New data including longer duration follow-up from SCD and TDT pivotal trials accepted for oral presentation –

- Five additional abstracts accepted for poster presentation -

. ....

United States , City Of , United Kingdom , Exagamglogene Autotemcel , Vertex Pharmaceuticals Incorporated Nasdaq , European Hematology Association Congress , Improvements In Health , Companies To Work , Occlusive Crisis On Health , American Society Of Hematology , Exchange Commission , Vertex Pharmaceuticals Incorporated , Annual Meeting , Severe Sickle Cell , Health Related Quality , Life After Exagamglogene Autotemcel , Transfusion Dependent Beta , Patients With Severe Sickle Cell , Status Among Patients , Cohort Study , Recent Vaso Occlusive Crisis , Sickle Cell , Sickle Cell Disease Prevalence , Model Using , Foreign Born State Specific Population , New England Journal ,